Skip to main content
logo
Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.640
-0.030 (-1.80%)
At close: Jan 2, 2026, 4:00 PM EST
1.630
-0.010 (-0.61%)
After-hours: Jan 2, 2026, 8:00 PM EST

Lineage Cell Therapeutics Revenue

Lineage Cell Therapeutics had revenue of $3.68M in the quarter ending September 30, 2025, a decrease of -2.59%. This brings the company's revenue in the last twelve months to $10.82M, up 24.05% year-over-year. In the year 2024, Lineage Cell Therapeutics had annual revenue of $9.50M with 6.19% growth.

Revenue (ttm)
$10.82M
Revenue Growth
+24.05%
P/S Ratio
35.01
Revenue / Employee
$140,468
Employees
77
Market Cap
397.42M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.50M554.00K6.19%
Dec 31, 20238.95M-5.76M-39.16%
Dec 31, 202214.70M10.36M238.70%
Dec 31, 20214.34M2.52M137.73%
Dec 31, 20201.83M-1.69M-48.05%
Dec 31, 20193.52M-1.47M-29.53%
Dec 31, 20184.99M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 20141.22M-3.21M-72.40%
Dec 31, 20134.43M518.67K13.25%
Dec 31, 20123.92M-4.87M-55.45%
Dec 31, 20118.79M1.40M18.96%
Dec 31, 20107.39M5.46M283.78%
Dec 31, 20091.93M421.38K28.02%
Dec 31, 20081.50M457.67K43.75%
Dec 31, 20071.05M142.92K15.82%
Dec 31, 2005903.20K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

LCTX News

More News